4,4',4''-Methanetriyltris(N,N-dimethylaniline)

Catalog No. :
ACPGVZ685
CAS No. :
603-48-5
Molecular Formula :
C25H31N3
Molecular Weight :
373.54

IUPAC Name:4,4',4''-methanetriyltris(N,N-dimethylaniline)

4,4',4''-Methanetriyltris(N,N-dimethylaniline) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g98%$68.00Login to see priceIn stockInquiry
1000g98%$124.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4',4''-Methanetriyltris(N,N-dimethylaniline)
IUPAC Name4,4',4''-methanetriyltris(N,N-dimethylaniline)
MDL No.MFCD00008314
Molecular FormulaC25H31N3
Molecular Weight373.54
SMILESCN(C)C1=CC=C(C(C2=CC=C(C=C2)N(C)C)C3=CC=C(C=C3)N(C)C)C=C1
InChI KeyOAZWDJGLIYNYMU-UHFFFAOYSA-N
SynonymLCV | 3vw1 | 4,4''-Methylidynetris(N,N-dimethylaniline) | 4-[bis[4-(dimethylamino)phenyl]methyl]-N,N-dimethylaniline | AS-66577 | CI BASIC VIOLET 3, LEUCO | PD065506 | A-DMA | AI3-19978 | LCV | Tris(4-(dimethylamino)phenyl)methane | AKOS015903459 | STL416
CAS No.603-48-5
PubChem CID69048

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPGVZ685 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBNPV839 route compound structure diagram
    ACBNPV839100-10-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8 In Stock
  6. Then
  7. ACPGVZ685 route product structure diagram
    ACPGVZ685603-48-5 In Stock
Inquiry

2. ACPGVZ685 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFPBU584 route compound structure diagram
    ACFPBU584467-63-0 In Stock
  2. Then
  3. ACPGVZ685 route product structure diagram
    ACPGVZ685603-48-5 In Stock
Inquiry

Comments (0)